Chinese Journal of Stroke ›› 2022, Vol. 17 ›› Issue (09): 957-965.DOI: 10.3969/j.issn.1673-5765.2022.09.008
Previous Articles Next Articles
Received:
2022-04-21
Online:
2022-09-20
Published:
2022-09-20
曹雨停,范文娟,王春雪,陈瑛
通讯作者:
王春雪 snowsen@126.com
陈瑛 chenying@ccmu.edu.cn
CAO Yuting, FAN Wenjuan, WANG Chunxue, CHEN Ying. Meta-analysis of the Association of Menopausal Hormone Therapy with Stroke [J]. Chinese Journal of Stroke, 2022, 17(09): 957-965.
曹雨停, 范文娟, 王春雪, 陈瑛. 绝经激素治疗与卒中相关性的meta分析 [J]. 中国卒中杂志, 2022, 17(09): 957-965.
[1] BUSHNELL C D. Oestrogen and stroke in women:assessment of risk[J]. Lancet Neurol,2005,4(11):743-751. [2] CHEN J,XU W,JIANG H. 17 beta-estradiol protects neurons from ischemic damage and attenuates accumulation of extracellular excitatory amino acids[J]. Anesth Analg,2001,92(6):1520-1523. [3] ANDERSON G L,LIMACHER M,ASSAF A R,et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy:the women's health initiative randomized controlled trial[J]. JAMA,2004,291(14):1701-1712. [4] ANGERER P,STÖRK S,KOTHNY W,et al. Effect of oral postmenopausal hormone replacement on progression of atherosclerosis:a randomized,controlled trial[J]. Arterioscler Thromb Vasc Biol,2001,21(2):262-268. [5] The Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen/progestin interventions(PEPI)trial[J]. JAMA,1996,275(5):370-375. [6] SCHIERBECK L L,REJNMARK L,TOFTENG C L,et al. Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women:randomised trial[J/OL]. BMJ,2012,345:e6409[2022-04-10]. https://doi.org/10.1136/bmj.e6409. [7] VEERUS P,HOVI S L,FISCHER K,et al. Results from the Estonian postmenopausal hormone therapy trial[ISRCTN35338757][J]. Maturitas,2006,55(2):162-173. [8] ROSSOUW J E,ANDERSON G L,PRENTICE R L,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women:principal results from the women's health initiative randomized controlled trial[J]. JAMA,2002,288(3):321-333. [9] CUMMINGS S R,ETTINGER B,DELMAS P D,et al. The effects of tibolone in older postmenopausal women[J]. N Engl J Med,2008,359(7):697-708. [10] GRODSTEIN F,MANSON J E,COLDITZ G A,et al. A prospective,observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease[J]. Ann Intern Med,2000,133(12):933-941. [11] WEINER M G,BARNHART K,XIE D,et al. Hormone therapy and coronary heart disease in young women[J]. Menopause,2008,15(1):86-93. [12] PRENTICE R L,LANGER R,STEFANICK M L,et al. Combined postmenopausal hormone therapy and cardiovascular disease:toward resolving the discrepancy between observational studies and the women's health initiative clinical trial[J]. Am J Epidemiol,2005,162(5):404-414. [13] LØKKEGAARD E,JOVANOVIC Z,HEITMANN B L,et al. Increased risk of stroke in hypertensive women using hormone therapy:analyses based on the Danish nurse study[J]. Arch Neurol,2003,60(10):1379-1384. [14] CASANOVA G,BOSSARDI RAMOS R,ZIEGELMANN P,et al. Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk:a systematic review and meta-analyses of randomized clinical trials[J]. J Clin Endocrinol Metab,2015,100(3):1028-1037. [15] SRIPRASERT I,HODIS H N,BERNICK B,et al. Effects of estradiol dose and serum estradiol levels on metabolic measures in early and late postmenopausal women in the REPLENISH trial[J]. J Womens Health(Larchmt),2020,29(8):1052-1058. [16] SALPETER S R,WALSH J M,ORMISTON T M,et al. Meta-analysis:effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women[J]. Diabetes Obes Metab,2006,8(5):538-554. [17] SUMINO H,ICHIKAWA S,SAWADA Y,et al. Effects of hormone replacement therapy on blood coagulation and fibrinolysis in hypertensive and normotensive postmenopausal women[J]. Thromb Res,2005,115(5):359-366. [18] STIRONE C,DUCKLES S P,KRAUSE D N. Multiple forms of estrogen receptor-alpha in cerebral blood vessels:regulation by estrogen[J/OL]. Am J Physiol Endocrinol Metab,2003,284(1):E184-E192[2022-04-10]. https://doi.org/10.1152/ajpendo.00165.2002. [19] RUSSELL K S,HAYNES M P,SINHA D,et al. Human vascular endothelial cells contain membrane binding sites for estradiol,which mediate rapid intracellular signaling[J]. Proc Natl Acad Sci USA,2000,97(11):5930-5935. [20] KOH P O,CHO G J,CHOI W S. 17beta-estradiol pretreatment prevents the global ischemic injury-induced decrease of Akt activation and bad phosphorylation in gerbils[J]. J Vet Med Sci,2006,68(10):1019-1022. [21] GARCIA-SEGURA L M,NAFTOLIN F,HUTCHISON J B,et al. Role of astroglia in estrogen regulation of synaptic plasticity and brain repair[J]. J Neurobiol,1999,40(4):574-584. [22] SORTINO M A,CHISARI M,MERLO S,et al. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death[J]. Endocrinology,2004,145(11):5080-5086. [23] YANG S H,LIU R,PEREZ E J,et al. Estrogens as protectants of the neurovascular unit against ischemic stroke[J]. Curr Drug Targets CNS Neurol Disord,2005,4(2):169-177. [24] PAGANINI-HILL A,ROSS R K,HENDERSON B E. Postmenopausal oestrogen treatment and stroke:a prospective study[J]. BMJ,1988,297(6647):519-522. [25] SIMON J A,HSIA J,CAULEY J A,et al. Postmenopausal hormone therapy and risk of stroke:the heart and estrogen-progestin replacement study(HERS)[J]. Circulation,2001,103(5):638-642. [26] VISCOLI C M,BRASS L M,KERNAN W N,et al. A clinical trial of estrogen-replacement therapy after ischemic stroke[J]. N Engl J Med,2001,345(17):1243-1249. [27] ZHANG Q G,RAZ L,WANG R,et al. Estrogen attenuates ischemic oxidative damage via an estrogen receptor alpha-mediated inhibition of NADPH oxidase activation[J]. J Neurosci,2009,29(44):13823-13836. [28] SCOTT E,ZHANG Q G,WANG R,et al. Estrogen neuroprotection and the critical period hypothesis[J]. Front Neuroendocrinol,2012,33(1):85-104. [29] GU H F,ZHAO X H,ZHAO X P,et al. Risk of stroke in healthy postmenopausal women during and after hormone therapy:a meta-analysis[J]. Menopause,2014,21(11):1204-1210. [30] MARJORIBANKS J,FARQUHAR C,ROBERTS H,et al. Long-term hormone therapy for perimenopausal and postmenopausal women[J/OL]. Cochrane Database Syst Rev,2012(7):CD004143[2022-04-10]. https://doi.org/10.1002/14651858.CD004143. [31] KIM J E,CHANG J H,JEONG M J,et al. A systematic review and meta-analysis of effects of menopausal hormone therapy on cardiovascular diseases[J/OL]. Sci Rep,2020,10(1):20631[2022-04-10]. https://doi.org/10.1038/s41598-020-77534-9. [32] MATTHEWS K A,KULLER L H,WING R R,et al. Prior to use of estrogen replacement therapy,are users healthier than nonusers?[J]. Am J Epidemiol,1996,143(10):971-978. [33] GRODSTEIN F,CLARKSON T B,MANSON J E. Understanding the divergent data on postmenopausal hormone therapy[J]. N Engl J Med,2003,348(7):645-650. [34] MCKENZIE J,JAAP A J,GALLACHER S,et al. Metabolic,inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes:potentially safer with respect to vascular risk?[J]. Clin Endocrinol(Oxf),2003,59(6):682-689. |
[1] | LU Yan, YANG Baorong, HUANG Xiangping, YANG Guangui, CHEN Shengwen, LI Jianrong, ZENG Xiaoming. MRI-Guided Thrombolysis beyond Time Window in Acute Ischemic Stroke in a County-Level Hospital: A Case-Control Study [J]. Chinese Journal of Stroke, 2022, 17(12): 1321-1326. |
[2] | CHU Yueqi, ZHOU Kaiyun, WANG Tianyan, WANG Jiongbin, LI Zhen. The Efficacy of Auricular Acupuncture Pressing for Post-Stroke Dysphagia: A Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(12): 1327-1334. |
[3] | ZHOU Tiantian, SU Wenjie, LIAN Songyong, LIN Youcong. Effects of Environmental Enrichment on Cognitive Function in Patients with Vascular Dementia after Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1343-1349. |
[4] | WU Yuqian, ZHANG Yumei, FAN Xiaowei, WANG Anxin, PANG Wenbin. The Efficacy of Kinesthetic Motor Imagery Therapy for Hand Function Rehabilitation of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(12): 1366-1371. |
[5] | JIANG Lin, LI Jing. Science Mapping Analysis of Artificial Intelligence Applied in Stroke Research [J]. Chinese Journal of Stroke, 2022, 17(12): 1372-1380. |
[6] | LIANG Xiao, QIAN Haibing. Progress of the Relationship between Aquaporin 4 and Post-Stroke Cognitive Impairment [J]. Chinese Journal of Stroke, 2022, 17(12): 1385-1390. |
[7] | WU Xiaoli, LIU Lixu. The Effect of Obesity on Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(12): 1391-1395. |
[8] | YI Luo, ZHOU Hongyu, QIU Xin, LI Zixiao, WANG Yongjun. DNA Methylation Changes in Atherosclerotic Diseases [J]. Chinese Journal of Stroke, 2022, 17(11): 1163-1170. |
[9] | WANG Yubo, LI Zixiao, WANG Yongjun. Progress of the Relationship between Epigenetics and Oxidative Stress after Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1171-1177. |
[10] | YAN Ran, MIN Yan, QUAN Kehua, LI Zixiao. Relationship between BDNF and SLC6A4 Gene Methylation and the Prognosis of Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1178-1182. |
[11] | CUI Lingyun, QIU Xin, ZHOU Hongyu, LI Zixiao, WANG Yongjun. Progress of the Relationship between DNA Methylation and Type 2 Diabetes [J]. Chinese Journal of Stroke, 2022, 17(11): 1183-1188. |
[12] | DENG Yuhan, LIU Shuang, WANG Ziyao, WANG Yuxin, LIU Baohua. The Effect of Machine Learning Model for Predicting Stroke Risk in the General Population Based on Structured Data: A Systematic Review and Meta-Analysis [J]. Chinese Journal of Stroke, 2022, 17(11): 1189-1197. |
[13] | LIU Guangliang, HAN Kaiyue, SU Wenlong, ZHANG Hao. Effects of Aerobic Cycling Training Intensity on Motor and Cardiopulmonary Fitness in Patients with Ischemic Stroke [J]. Chinese Journal of Stroke, 2022, 17(11): 1203-1208. |
[14] | SUN Moyi, ZHANG Yumei, LIU Ran, ZHAO Yishuang. Effect of Rehabilitation at Different Timing after Stroke on Motor Function of Stroke Patients [J]. Chinese Journal of Stroke, 2022, 17(11): 1209-1215. |
[15] | HU Hongmei, YANG Lei, YU Ling, QIN Wei, BAI Mingyue, HU Wenli. Clinical Features of Acute Single Small Cerebellar Infarction [J]. Chinese Journal of Stroke, 2022, 17(11): 1221-1226. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||